Avia Vascular is a medical device manufacturer providing a family of needle-free blood collection devices intended to reduce the need for venipuncture when obtaining blood samples in patients with an established peripheral IV catheter. Our primary objective is to provide a needle-free alternative for the inpatient and ED populations that enhances the patient experience, improves outcomes, and reduces overall provider costs.
Who We Are.
At the core, Avia Vascular is a team of innovators and business specialists with a shared desire to solve meaningful problems and improve the quality of healthcare worldwide. Our company leverages strategic partnerships to yield “big business” capability while ensuring “small business” adaptability. With expertise in fields of business development, marketing, engineering, manufacturing, finance, quality, and regulatory, we view problems from multiple perspectives and utilize the strength of the team to create robust solutions. We are passionate about our work and dedicated to our mission of developing new technologies that exceed expectations.
Our Team
KEVIN COOK
CEO
PAUL BLACKBURN,
MNA, RN
VP Clinical Development
DAN HIGGS
Chief IP Counsel
MICHAEL PELL
Engineering Manager
CHAD NIELSON
Dir. Quality
& Operations
Our Investor
Avia Vascular is a subsidiary of MedVenture Health (MVH). MVH partners with entrepreneurs, physicians, and management teams to advance healthcare products, services, and technologies. MVH provides expertise and capital resources to assist in creating value; investing in healthcare companies at a stage in their development where an infusion of capital and strategic assistance will significantly enhance value.